Not logged in Share Save
Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113) (vol 7, 100552, 2024) Hartlapp, I.; Valta-Seufzer, D.; Siveke, J. T.; Alguel, H.; Goekkurt, E.; Siegler, G.; Martens, U. M.; Waldschmidt, D.; Pelzer, U.; Fuchs, M.; Kullmann, F.; Boeck, S.; Ettrich, T. J.; Held, S.; Keller, R.; Anger, F.; Germer, C. T.; Stang, A.; Kimmel, B.; Heinemann, V.; Kunzmann, V. Share Save
Alternating gemcitabine plus nab-paclitaxel and gemcitabine alone versus continuous gemcitabine plus nab-paclitaxel after induction treatment of metastatic pancreatic cancer (ALPACA): a multicentre, randomised, open-label, phase 2 trial Dorman, Klara; Boeck, Stefan; Caca, Karel; Reichert, Maximilian; Ettrich, Thomas J.; Oettle, Helmut; Waidmann, Oliver; Modest, Dominik P.; Mueller, Lothar; Michl, Patrick; Kanzler, Stephan; Pink, Daniel; Reinacher-Schick, Anke; Geissler, Michael; Pelz, Henning; Kunzmann, Volker; Held, Swantje; Schichtl, Thomas; Heinemann, Volker; Kullmann, Frank Share Save
Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113) (vol 7, 100552, 2024) Hartlapp, I.; Valta-Seufzer, D.; Siveke, J. T.; Alguel, H.; Goekkurt, E.; Siegler, G.; Martens, U. M.; Waldschmidt, D.; Pelzer, U.; Fuchs, M.; Kullmann, F.; Boeck, S.; Ettrich, T. J.; Held, S.; Keller, R.; Anger, F.; Germer, C. T.; Stang, A.; Kimmel, B.; Heinemann, V.; Kunzmann, V. Share Save
Ramucirumab, Avelumab, and Paclitaxel as Second-Line Treatment in Esophagogastric Adenocarcinoma: The Phase 2 RAP (AIO-STO-0218) Nonrandomized Controlled Trial Thuss-Patience, Peter; Hoegner, Anica; Goekkurt, Eray; Stahl, Michael; Kretzschmar, Albrecht; Goetze, Thorsten; Stocker, Gertraud; Reichardt, Peter; Kullmann, Frank; Pink, Daniel; Bartels, Prisca; Jarosch, Armin; Hinke, Axel; Schultheiss, Christoph; Paschold, Lisa; Stein, Alexander; Binder, Mascha Share Save
Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113) Hartlapp, I; Valta-Seufzer, D.; Siveke, J. T.; Algul, H.; Goekkurt, E.; Siegler, G.; Martens, U. M.; Waldschmidt, D.; Pelzer, U.; Fuchs, M.; Kullmann, F.; Boeck, S.; Ettrich, T. J.; Held, S.; Keller, R.; Anger, F.; Germer, C. T.; Stang, A.; Kimmel, B.; Heinemann, V; Kunzmann, V Share Save
Single-nucleotide variants, tumour mutational burden and microsatellite instability in patients with metastatic colorectal cancer: Next-generation sequencing results of the FIRE-3 trial (vol 137, pg 250, 2020) Stahler, Arndt; Stintzing, Sebastian; von Einem, Jobst C.; Westphalen (Benedikt), Christoph B.; Heinrich, Kathrin; Kraemer, Nicole; Michl, Marlies; Modest, Dominik P.; von Weikersthal, Ludwig Fischer; Decker, Thomas; Kiani, Alexander; Heintges, Tobias; Kahl, Christoph; Kullmann, Frank; Scheithauer, Werner; Moehler, Markus; Kaiser, Florian; Kirchner, Thomas; Jung, Andreas; Heinemann, Volker Share Save
Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3 Fischer, Laura E.; Stintzing, Sebastian; von Weikersthal, Ludwig Fischer; Modest, Dominik P.; Decker, Thomas; Kiani, Alexander; Kaiser, Florian; Al-Batran, Salah-Eddin; Heintges, Tobias; Lerchenmueller, Christian; Kahl, Christoph; Seipelt, Gernot; Kullmann, Frank; Stauch, Martina; Scheithauer, Werner; Giessen-Jung, Clemens; Uhlig, Jens; Peuser, Bettina; Denzlinger, Claudio; Stahler, Arndt; Weiss, Lena; Heinrich, Kathrin; Held, Swantje; Jung, Andreas; Kirchner, Thomas; Heinemann, Volker Share Save
Survival after secondary liver resection in metastatic colorectal cancer: Comparing data of three prospective randomized European trials (LICC, CELIM, FIRE-3) Moehler, Markus; Folprecht, Gunnar; Heinemann, Volker; Holch, Julian Walter; Maderer, Annett; Kasper, Stefan; Hegewisch-Becker, Susanna; Schroeder, Jan; Overkamp, Friedrich; Kullmann, Frank; Bechstein, Wolf Otto; Voehringer, Matthias; Oellinger, Robert; Lordick, Florian; Geissler, Michael; Schulz-Abelius, Armin; Linz, Bernhard; Bernhard, Helga; Paul, Andreas; Schmidtmann, Irene; Potthoff, Karin; Schimanski, Carl Christoph Share Save
Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306) Liu, Lian; Erickson, Nicole Tonya; Ricard, Ingrid; von Weikersthal, Ludwig Fischer; Lerch, Markus M.; Decker, Thomas; Kiani, Alexander; Kaiser, Florian; Heintges, Tobias; Kahl, Christoph; Kullmann, Frank; Scheithauer, Werner; Link, Hartmut; Hoeffkes, Heinz-Gert; Moehler, Markus; Gesenhues, Alena Britta; Theurich, Sebastian; Michl, Marlies; Modest, Dominik P.; Alguel, Hana; Stintzing, Sebastian; Heinemann, Volker; Holch, Julian W. Share Save
Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multi-agent induction chemotherapy: Results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113) Hartlapp, I.; Valta-Seufzer, D.; Siveke, J.; Alguel, H.; Goekkurt, E.; Siegler, G. M.; Martens, U. M.; Waldschmidt, D.; Pelzer, U.; Fuchs, M.; Kullmann, F.; Boeck, S.; Ettrich, T. J.; Held, S.; Keller, R.; Anger, F.; Germer, C-T.; Stang, H. A.; Heinemann, V.; Kunzmann, V. Share Save
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial Kunzmann, Volker; Siveke, Jens T.; Alguel, Hana; Goekkurt, Eray; Siegler, Gabriele; Martens, Uwe; Waldschmidt, Dirk; Pelzer, Uwe; Fuchs, Martin; Kullmann, Frank; Boeck, Stefan; Ettrich, Thomas J.; Held, Swantje; Keller, Ralph; Klein, Ingo; Germer, Christoph-Thomas; Stein, Hubert; Friess, Helmut; Bahra, Marcus; Jakobs, Ralf; Hartlapp, Ingo; Heinemann, Volker Share Save
FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial Heinemann, Volker; von Weikersthal, Ludwig Fischer; Decker, Thomas; Kiani, Alexander; Kaiser, Florian; Al-Batran, Salah-Edin; Heintges, Tobias; Lerchenmuller, Christoph; Kahl, Christoph; Seipelt, Gernot; Kullmann, Frank; Moehler, Markus; Scheithauer, Werner; Held, Swantje; Miller-Phillips, Lisa; Modest, Dominik Paul; Jung, Andreas; Kirchner, Thomas; Stintzing, Sebastian Share Save
Modified FOLFOX versus modified FOLFOX plus nivolumab and ipilimumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction - Safety Results from AIO-STO-0417: A randomized phase II trial of the German Gastric Group of the AIO Pauligk, C.; Goetze, T. O.; Thuss-Patience, P. C.; Riera-Knorrenschild, J.; Goekkurt, E.; Ettrich, T. J.; Pink, D.; Lindig, U.; Luley, K. B.; Dechow, T.; Bitzer, M.; Angermeier, S.; Homann, N.; Kullmann, F.; Schuch, G.; Bolling, C.; Junge, S.; Hofheinz, R. D.; Lorenzen, S.; Al-Batran, S-E. Share Save
Evaluation of conversion therapy in patients undergoing secondary resection of metastases in curative intent within the FIRE-3 (AIO KRK-0306) study von Einem, J. C.; Heinemann, V.; Modest, D. P.; Stahler, A.; Miller-Phillips, L.; von Weikersthal, L. Fischer; Decker, T.; Kiani, A.; Vehling-Kaiser, U.; Al-Batran, S-E.; Kahl, C.; Seipelt, G.; Kullmann, F.; Scheithauer, W.; Jung, A.; Kirchner, T.; Stintzing, S. Share Save
Single-nucleotide variants, tumour mutational burden and microsatellite instability in patients with metastatic colorectal cancer: Next-generation sequencing results of the FIRE-3 trial Stahler, Arndt; Stintzing, Sebastian; von Einem, Jobst C.; Westphalen (Benedikt), Christoph B.; Heinrich, Kathrin; Kraemer, Nicole; Michl, Marlies; Modest, Dominik P.; von Weikersthal, Ludwig Fischer; Decker, Thomas; Kiani, Alexander; Heintges, Tobias; Kahl, Christoph; Kullmann, Frank; Scheithauer, Werner; Moehler, Markus; Kaiser, Florian; Kirchner, Thomas; Jung, Andreas; Heinemann, Volker Share Save
Adjuvant MUC vaccination with tecemotide after resection of colorectal liver metastases: a randomized, double-blind, placebo-controlled, multicenter AIO phase II trial (LICC) Schimanski, Carl Christoph; Kasper, Stefan; Hegewisch-Becker, Susanna; Schroeder, Jan; Overkamp, Friedrich; Kullmann, Frank; Bechstein, Wolf Otto; Voehringer, Matthias; Oellinger, Robert; Lordick, Florian; Heinemann, Volker; Geissler, Michael; Schulz-Abelius, Armin; Bernhard, Helga; Schoen, Michael R.; Greil, Richard; Galle, Peter; Lang, Hauke; Schmidtmann, Irene; Moehler, Markus Share Save
Phase III randomized, double-blind study of paclitaxel with and without everolimus in patients with advanced gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum-containing regimen (RADPAC) Lorenzen, Sylvie; Knorrenschild, Jorge Riera; Pauligk, Claudia; Hegewisch-Becker, Susanna; Seraphin, Joerg; Thuss-Patience, Peter; Kopp, Hans-Georg; Dechow, Tobias; Vogel, Arndt; Luley, Kim Barbara; Pink, Daniel; Stahl, Michael; Kullmann, Frank; Hebart, Holger; Siveke, Jens; Egger, Matthias; Homann, Nils; Probst, Stephan; Goetze, Thorsten Oliver; Al-Batran, Salah-Eddin Share Save
Relation of cetuximab-induced skin toxicity and early tumor shrinkage in metastatic colorectal cancer patients: results of the randomized phase 3 trial FIRE-3 (AIO KRK0306) Holch, J. W.; Held, S.; Stintzing, S.; von Weikersthal, L. Fischer; Decker, T.; Kiani, A.; Kaiser, F.; Heintges, T.; Kahl, C.; Kullmann, F.; Scheithauer, W.; Moehler, M.; von Einem, J. C.; Michl, M.; Heinemann, V Share Save
Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial Stintzing, S.; Wirapati, P.; Lenz, H. J.; Neureiter, D.; von Weikersthal, L. Fischer; Decker, T.; Kiani, A.; Kaiser, F.; Al-Batran, S.; Heintges, T.; Lerchenmueller, C.; Kahl, C.; Seipelt, G.; Kullmann, F.; Moehler, M.; Scheithauer, W.; Held, S.; Modest, D. P.; Jung, A.; Kirchner, T.; Aderka, D.; Tejpar, S.; Heinemann, V Share Save
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png)
ANNALS OF ONCOLOGY.png)
OAAI
.png){kind=icon}
Share.png){kind=icon}
Save